scholarly article | Q13442814 |
P356 | DOI | 10.1309/K144PHVDDUPDD401 |
P698 | PubMed publication ID | 14983936 |
P50 | author | Christine A Iacobuzio-Donahue | Q58327762 |
P2093 | author name string | Raheela Ashfaq | |
Lynette S Nichols | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pancreatic cancer | Q212961 |
P304 | page(s) | 226-230 | |
P577 | publication date | 2004-02-01 | |
P1433 | published in | American Journal of Clinical Pathology | Q15750224 |
P1476 | title | Claudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target | |
P478 | volume | 121 |
Q89077427 | Advances in Diagnostic and Intraoperative Molecular Imaging of Pancreatic Cancer |
Q34788669 | C terminus of Clostridium perfringens enterotoxin downregulates CLDN4 and sensitizes ovarian cancer cells to Taxol and Carboplatin |
Q33814933 | Challenges associated with the targeted delivery of gelonin to claudin-expressing cancer cells with the use of activatable cell penetrating peptides to enhance potency |
Q42476256 | Changes of cell adhesion and extracellular matrix (ECM) components in cervical intraepithelial neoplasia |
Q58001856 | Claudin 1 overexpression increases invasion and is associated with aggressive histological features in oral squamous cell carcinoma |
Q37611453 | Claudin and ovarian cancer |
Q54646160 | Claudin expression in Barrett's esophagus and adenocarcinoma. |
Q80148403 | Claudin expression in pancreatic endocrine tumors as compared with ductal adenocarcinomas |
Q28287255 | Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study |
Q30491616 | Claudin-4 Expression is Associated With Survival in Ovarian Cancer But Not With Chemotherapy Response |
Q40355382 | Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas |
Q33967794 | Claudin-4 expression in gastric cancer cells enhances the invasion and is associated with the increased level of matrix metalloproteinase-2 and -9 expression |
Q36244220 | Claudin-4 expression is associated with tumor invasion, MMP-2 and MMP-9 expression in gastric cancer |
Q35756974 | Claudin-4 overexpression in epithelial ovarian cancer is associated with hypomethylation and is a potential target for modulation of tight junction barrier function using a C-terminal fragment of Clostridium perfringens enterotoxin |
Q39335167 | Claudin-4-targeted optical imaging detects pancreatic cancer and its precursor lesions |
Q39651156 | Claudin-6, 7, or 9 overexpression in the human gastric adenocarcinoma cell line AGS increases its invasiveness, migration, and proliferation rate. |
Q35681850 | Claudins and ki-67: potential markers to differentiate low- and high-grade transitional cell carcinomas of the urinary bladder |
Q37400120 | Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases -2 expression in ovarian carcinoma |
Q47157718 | Convenient Preparation of 18F-Labeled Peptide Probes for Potential Claudin-4 PET Imaging. |
Q40164661 | Correlation between Claudins Expression and Prognostic Factors in Prostate Cancer |
Q40257166 | DNA-methylation-dependent alterations of claudin-4 expression in human bladder carcinoma. |
Q53565622 | Decreased expression of claudin-3 is associated with a poor prognosis and EMT in completely resected squamous cell lung carcinoma. |
Q45717757 | Detection of claudin-4 in salivary gland neoplasms (a study utilizing RT-PCR and immunohistochemistry). |
Q61773593 | Differential expression of genes encoding tight junction proteins in colorectal cancer: frequent dysregulation of claudin-1, -8 and -12 |
Q36796253 | Distinct claudin expression profiles of hepatocellular carcinoma and metastatic colorectal and pancreatic carcinomas |
Q28507165 | Dynamic distribution of claudin proteins in pancreatic epithelia undergoing morphogenesis or neoplastic transformation |
Q37225107 | Emerging roles of claudins in human cancer |
Q84290461 | Expression of claudin 10 protein in hepatocellular carcinoma: impact on survival |
Q39628515 | Expression of claudin-4 (CLDN4) mRNA in intraductal papillary mucinous neoplasms of the pancreas. |
Q30437572 | Expression of tight-junction protein claudin-7 is an early event in gastric tumorigenesis |
Q37338056 | Expression transformation of claudin-1 in the process of gastric adenocarcinoma invasion |
Q37696662 | Gene expression profile regulated by the HPV16 E7 oncoprotein and estradiol in cervical tissue |
Q40795286 | Gene expression profiles associated with advanced pancreatic cancer. |
Q33526567 | High-resolution light microscopy using luminescent nanoparticles |
Q36858042 | Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer |
Q47903216 | Imaging of Claudin-4 in Pancreatic Ductal Adenocarcinoma Using a Radiolabelled Anti-Claudin-4 Monoclonal Antibody |
Q33412483 | Imaging pancreatic cancer using bioconjugated InP quantum dots |
Q37386754 | Immobilization of biomolecules on the surface of inorganic nanoparticles for biomedical applications |
Q51547379 | Increased expressions of claudin 4 and 7 in atypical adenomatous hyperplasia and adenocarcinoma of the lung. |
Q42476044 | Increased expressions of claudin-1 and claudin-7 during the progression of cervical neoplasia |
Q64890641 | MetaGxData: Clinically Annotated Breast, Ovarian and Pancreatic Cancer Datasets and their Use in Generating a Multi-Cancer Gene Signature. |
Q30393523 | Molecular Imaging of Pancreatic Cancer with Antibodies |
Q36485336 | Molecular genetics of pancreatic ductal adenocarcinomas and recent implications for translational efforts |
Q33543746 | Multifunctional Nanoparticles as Biocompatible Targeted Probes for Human Cancer Diagnosis and Therapy |
Q48293480 | Nanotechnologies in Pancreatic Cancer Therapy |
Q30489770 | New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8. |
Q33834277 | Non-invasive tumor detection in small animals using novel functional Pluronic nanomicelles conjugated with anti-mesothelin antibody. |
Q35582711 | Overexpression of Claudin-1 is Associated with Advanced Clinical Stage and Invasive Pathologic Characteristics of Oral Squamous Cell Carcinoma |
Q36773924 | Overexpression of claudin-4 may be involved in endometrial tumorigenesis |
Q26787279 | Paradigms lost-an emerging role for over-expression of tight junction adhesion proteins in cancer pathogenesis |
Q37370600 | Patterns of EphA2 protein expression in primary and metastatic pancreatic carcinoma and correlation with genetic status |
Q30458493 | Phase-change nanoparticles using highly volatile perfluorocarbons: toward a platform for extravascular ultrasound imaging |
Q51735492 | Plectin-1 Targeted Dual-modality Nanoparticles for Pancreatic Cancer Imaging. |
Q35965742 | Quantitative molecular profiling of biomarkers for pancreatic cancer with functionalized quantum dots |
Q38821198 | Roles of the first-generation claudin binder, Clostridium perfringens enterotoxin, in the diagnosis and claudin-targeted treatment of epithelium-derived cancers |
Q37038590 | Serial analysis of gene expression of lobular carcinoma in situ identifies down regulation of claudin 4 and overexpression of matrix metalloproteinase 9. |
Q47633338 | Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients. |
Q36685675 | Target discovery and validation in pancreatic cancer |
Q21260426 | The claudin gene family: expression in normal and neoplastic tissues |
Q48002827 | The prognostic role of claudins in head and neck squamous cell carcinomas |
Q38223244 | The role of epithelial tight junctions involved in pathogen infections |
Q55483367 | Therapeutic antibodies for the treatment of pancreatic cancer. |
Q38957238 | Universal antibody conjugation to nanoparticles using the Fcγ receptor I (FcγRI): quantitative profiling of membrane biomarkers |
Q51476559 | Usefulness of Claudin 4 in the cytological diagnosis of serosal effusions. |
Search more.